Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LZM008 vs Tocilizumab in Moderate to Severe Rheumatoid Arthritis
CTR20191204Phase 3Completed
- Sponsor
- Livzon Monoclonal Antibody
- Start
- Jun 2019
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of LZM008 in rheumatoid arthritis (RA), sponsored by Livzon Monoclonal Antibody. Started Jun 2019; status: completed.
02
Drugs
LZM008
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on CTR20191204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20191204.